GeneDx Holdings, Clinical Diagnostics — Profile, Headquarters & News

Last updated Jun 5, 2026

About

GeneDx operates a data-driven clinical diagnostics business model focused on rare and ultra-rare disease testing, emphasizing its whole genome sequencing and whole exome sequencing tests as primary growth drivers. The company derives the bulk of its revenue from clinical diagnostic testing, billing payers for ordering genome and exome tests.

Structure & People

Corporate Family

GeneDx Holdings

Industry

Medical and Diagnostic Laboratories

This industry comprises establishments known as medical and diagnostic laboratories primarily engaged in providing analytic or diagnostic services, including body fluid analysis and diagnostic imaging, generally to the medical profession or to the patient on referral from a health practitioner. Illustrative Examples: Dental or medical X-ray laboratories Medical pathology laboratories Diagnostic imaging centers Medical testing laboratories Medical forensic laboratories Cross-References.

Acquisitions

Fabric Genomics Completed

Acquired May 2025 $33.2M expand the company's addressable market with multiple scalable revenue streams and transform[] static data into a dynamic, recurring revenue-generating platform – driving growth through software margins and high-leverage interpretation services across geographies and clinical use cases.